GENE ONLINE|News &
Opinion
Blog

Alexion Pharmaceuticals
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
Taiwanese Government Grants 16 Million to aid Adimmune’s COVID-19 Vaccine Trials
2020-10-24
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Weekly in Asia|Nov-1
2019-11-19
LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!